Teladoc Health, Inc. (NYSE:TDOC) Shares Purchased by Walleye Capital LLC

Walleye Capital LLC raised its stake in shares of Teladoc Health, Inc. (NYSE:TDOCGet Rating) by 121.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,896 shares of the health services provider’s stock after buying an additional 8,731 shares during the period. Walleye Capital LLC’s holdings in Teladoc Health were worth $1,147,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Wade G W & Inc. acquired a new position in shares of Teladoc Health in the 1st quarter worth approximately $224,000. Western Wealth Management LLC acquired a new position in shares of Teladoc Health in the 1st quarter worth approximately $216,000. Shell Asset Management Co. grew its stake in shares of Teladoc Health by 3.5% in the 1st quarter. Shell Asset Management Co. now owns 12,418 shares of the health services provider’s stock worth $896,000 after purchasing an additional 423 shares during the last quarter. LGT Group Foundation grew its stake in shares of Teladoc Health by 151.4% in the 1st quarter. LGT Group Foundation now owns 28,534 shares of the health services provider’s stock worth $2,106,000 after purchasing an additional 17,184 shares during the last quarter. Finally, Lincoln National Corp grew its stake in shares of Teladoc Health by 42.7% in the 1st quarter. Lincoln National Corp now owns 3,955 shares of the health services provider’s stock worth $285,000 after purchasing an additional 1,184 shares during the last quarter. Institutional investors and hedge funds own 92.46% of the company’s stock.

Analyst Upgrades and Downgrades

TDOC has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Teladoc Health from $44.00 to $34.00 in a research note on Friday, July 29th. Truist Financial started coverage on shares of Teladoc Health in a report on Wednesday, September 7th. They issued a “hold” rating and a $35.00 target price for the company. DA Davidson started coverage on shares of Teladoc Health in a report on Friday, August 12th. They issued a “buy” rating and a $45.00 target price for the company. Barclays decreased their target price on shares of Teladoc Health from $45.00 to $42.00 and set an “equal weight” rating for the company in a report on Wednesday, July 20th. Finally, Oppenheimer decreased their target price on shares of Teladoc Health from $65.00 to $55.00 and set an “outperform” rating for the company in a report on Thursday, July 28th. Two research analysts have rated the stock with a sell rating, twenty-four have assigned a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $66.88.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Arnnon Geshuri sold 4,098 shares of the business’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $34.27, for a total value of $140,438.46. Following the sale, the insider now owns 76,182 shares of the company’s stock, valued at approximately $2,610,757.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, CFO Mala Murthy sold 4,053 shares of the company’s stock in a transaction dated Monday, June 27th. The shares were sold at an average price of $37.32, for a total transaction of $151,257.96. Following the transaction, the chief financial officer now owns 27,295 shares in the company, valued at approximately $1,018,649.40. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Arnnon Geshuri sold 4,098 shares of the company’s stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $34.27, for a total transaction of $140,438.46. Following the transaction, the insider now owns 76,182 shares in the company, valued at approximately $2,610,757.14. The disclosure for this sale can be found here. Insiders have sold 10,151 shares of company stock valued at $370,316 in the last 90 days. 1.55% of the stock is currently owned by company insiders.

Teladoc Health Trading Down 4.4 %

Shares of TDOC stock opened at $30.49 on Monday. Teladoc Health, Inc. has a 1 year low of $27.38 and a 1 year high of $156.82. The firm’s fifty day simple moving average is $36.06 and its 200 day simple moving average is $43.49. The firm has a market capitalization of $4.91 billion, a P/E ratio of -0.50 and a beta of 0.86. The company has a current ratio of 3.38, a quick ratio of 3.22 and a debt-to-equity ratio of 0.25.

Teladoc Health (NYSE:TDOCGet Rating) last announced its quarterly earnings results on Wednesday, July 27th. The health services provider reported ($0.44) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.71) by $0.27. The firm had revenue of $592.38 million for the quarter, compared to analyst estimates of $586.86 million. Teladoc Health had a negative net margin of 441.94% and a negative return on equity of 2.04%. As a group, sell-side analysts predict that Teladoc Health, Inc. will post -1.54 EPS for the current year.

About Teladoc Health

(Get Rating)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.

Featured Articles

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOCGet Rating).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.